4//SEC Filing
Jacobs Ian Seth 4
Accession 0001213900-20-030539
CIK 0001769804other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 5:56 PM ET
Size
5.4 KB
Accession
0001213900-20-030539
Insider Transaction Report
Form 4
Augmedix, Inc.NONE
Jacobs Ian Seth
DirectorPresident, Secretary CEO & CFO
Transactions
- Other
Common stock, par value $0.0001 per share
2020-10-05−90,000→ 160,000 total
Footnotes (1)
- [F1]Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of October 5, 2020, by and among the Issuer, August Acquisition Corp. ("Acquisition Sub"), and Augmedix Operating Company (f/k/a Augmedix, Inc.) ("Augmedix"), on October 5, 2020, Acquisition Sub merged with and into Augmedix, with Augmedix continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 90,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger
Documents
Issuer
Augmedix, Inc.
CIK 0001769804
Entity typeother
Related Parties
1- filerCIK 0001707297
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 5:56 PM ET
- Size
- 5.4 KB